We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rexahn Pharmaceuticals Submits Serdaxin® Phase II Protocol to FDA for Parkinson’s Disease

News   Apr 07, 2010

 
Rexahn Pharmaceuticals Submits Serdaxin® Phase II Protocol to FDA for Parkinson’s Disease
 
 
 

RELATED ARTICLES

Child Malaria Vaccine Pilot Launched in Malawi

News

WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine today in a landmark pilot programme. The country is the first of three in Africa in which the vaccine, known as RTS,S, will be made available to children up to 2 years of age; Ghana and Kenya will introduce the vaccine in the coming weeks.

READ MORE

Blood Test Detects 16 Out of 18 Breast Cancer Relapse Cases

News

A simple blood test for breast cancer relapse raises the possibility of easy monitoring of patients, which would provide a critical window of opportunity for earlier treatment than by other current tests.

READ MORE

Voice Analysis Explored for PTSD Diagnosis

News

A specially designed computer program can help diagnose post-traumatic stress disorder in veterans by analyzing their voices with 89 % accuracy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE